First City Capital Management, Inc. Ionis Pharmaceuticals Inc Transaction History

First City Capital Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$45.3 - $60.27 $240,316 - $319,732	-5,305 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$47.45 - $62.95 $69,988 - $92,851	1,475 Added 38.51%	5,305 $251,000
Q2 2020 Aug 14, 2020	BUY	$46.85 - $61.05 $179,435 - $233,821	3,830 New	3,830 $226,000
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $159,328 - $242,822	-3,830 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$52.92 - $81.17 $79,380 - $121,755	-1,500 Reduced 28.14%	3,830 $311,000

Q2 2017 Aug 14, 2017	BUY	N/A	5,330	5,330 $271,000

396

122M

854K

464K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $6.76B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of First City Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on First City Capital Management, Inc. with notifications on news.